SCHEMBL31400306

SCHEMBL31400306

COc1ccc2c(C(=O)O)cnn2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
DYRK1A Q13627 1/20 0.44
CCNK O75909 1/20 0.42
CDK12 Q9NYV4 1/20 0.42
GSK3B P49841 6/20 0.39
CDK4 P11802 3/20 0.39
CDK2 P24941 4/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
PABPC1 P11940 1/20 0.36
PTGS2 P35354 1/20 0.35
NNMT P40261 2/20 0.35
MYC P01106 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4469746 0.88 DYRK1A (0.44) POLBTDP1DYRK1ACCNKCDK12
SCHEMBL20839878 0.86 KMT2A (0.45) DYRK1ACCNKCDK12GSK3BCDK4
SCHEMBL4474522 0.78 DYRK1A (0.43) POLBTDP1DYRK1ACCNKCDK12
SCHEMBL4474513 0.78 DYRK1A (0.43) POLBTDP1DYRK1ACCNKCDK12
SCHEMBL4801800 0.77 TUBB4A (0.46)
SCHEMBL31400363 0.74 DYRK1A (0.46) DYRK1ACCNKCDK12GSK3BCDK4
SCHEMBL20839694 0.73 DYRK1A (0.48) DYRK1ACCNKCDK12GSK3BCDK4
SCHEMBL4479580 0.73 CDK4 (0.43) DYRK1AGSK3BCDK4CDK2ALDH1A1
SCHEMBL20839754 0.69 SPR (0.44) TDP1DYRK1ACCNKCDK12KDM4E
SCHEMBL21816255 0.69 KDM4E (0.46) POLBKDM4EALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059165-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-02-20 US disclosed
WO-2025031918-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250059165-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN QPCT, QPCTL, GLUL POLB 844/4885TDP1 3082/4885DYRK1A 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.